Six weeks of GLP-1 infusion resulted in significant improvements in fasting (decrease of 4.3 mM glucose) and 8 h mean glucose (decrease of 5.5 mM), fasting and mean 8h free fatty acids, a reduction in HbA1c from 9.2% to 7.9%, a decrease in fructosamine from 349 uM to 282 uM, and a reduction in gastric emptying 3,4
doi: 10.1016/j.brainres.2018.05.040 134
NNF21OC0070347) and a grant from EFSD/Lilly European Diabetes Research Programme
Combined application with other therapies Combined with exercise: AOD 9604 can enhance exercise-induced lipolysis and improve fat loss efficiency
However, previous reviews emphasize common mechanistic pathways such as inflammation and oxidative stress while emerging pathways particularly autophagy-related signaling are under explored
In the latest studies, both Retatrutide & Pemvidutide proved to have the potential to aid with cardiometabolic improvements, such as blood pressure, cholesterol, fasting glucose, glycated hemoglobin, & triglycerides